Pearce IP BioBlast w/e 22 March 2024
On 22 March 2024, the first case management hearing was held before Justice Nicholas in the Federal Court of Australia, Sydney, in proceedings…
Source: lexology.com
New Indication Alert News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from New Indication Alert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In New Indication Alert Today - Breaking & Trending Today
Pearce IP BioBlast w/e 26 Jan 2024
AbbVie announced it will invest US$233M in its biologics manufacturing facility in Singapore. The investment will add 24,000L of biologics…
Source: lexology.com
BioBlast w/e 15 Dec 23
Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…
Source: lexology.com
BioBlast w/e 17 Nov 23
AstraZeneca (AZ) announced the FDA approved its Truqap® (capivasertib) in combination with Faslodex (fulvestrant) for the treatment of adult patients…
Source: lexology.com
BioBlast w/e 03 Nov 23
Merck announced that the US FDA has approved Keytruda® (pembrolizumab) for the treatment of patients with locally advanced unresectable or metastatic…
Source: lexology.com